Suppr超能文献

非洲裔欧洲裔狼疮肾炎患者的长期肾脏预后更差。

Worse long-term renal outcome of lupus nephritis patients of African descent living in Europe.

机构信息

Service de médecine interne, CHU Nantes, Nantes, France

Rheumatology, Cliniques universitaires Saint-Luc, Bruxelles, Belgium.

出版信息

RMD Open. 2022 Oct;8(2). doi: 10.1136/rmdopen-2022-002386.

Abstract

INTRODUCTION

Prognosis of lupus nephritis (LN) among patients of African descent living in Europe has been understudied.

METHODS

In a retrospective study performed in two European university hospitals, we compared the prognosis of LN in patients of African descent or Caucasians. Remission was defined as a urine protein to creatinine (uP/C) ratio<0.5 g/g and a serum creatinine value<120% of baseline. Renal relapse was defined as the reappearance of a uP/C>1 g/g, leading to a repeat kidney biopsy and/or immunosuppressive treatment change. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate≤60 mL/min/1.73 m. Adherence was retrospectively assessed through medical files and/or hydroxychloroquine level measurements.

RESULTS

52 patients of African descent and 85 Caucasian patients were included in this analysis. Class III and isolated class V LN were more common among patients of African descent. Time to first renal remission did not differ between ethnic subgroups. By contrast, patients of African descent suffered from earlier renal flares, CKD was more common and time to CKD was shorter after a flare. In a multivariate analysis, African ancestry was an independent risk factor for progression to CKD. We observed no significant difference in non-adherence to treatment between the two groups.

CONCLUSION

LN patients of African descent have worse renal outcomes, mainly explained by a higher rate of renal flare.

摘要

简介

在欧洲生活的非洲裔患者的狼疮肾炎(LN)预后尚未得到充分研究。

方法

在两项欧洲大学医院进行的回顾性研究中,我们比较了非洲裔和高加索人 LN 患者的预后。缓解定义为尿蛋白与肌酐(uP/C)比值<0.5 g/g 和血清肌酐值<120%的基线值。肾脏复发定义为 uP/C>1 g/g 的再次出现,导致重复进行肾脏活检和/或免疫抑制治疗改变。慢性肾脏病(CKD)定义为估算肾小球滤过率≤60 mL/min/1.73 m。通过病历和/或羟氯喹水平测量来回顾性评估依从性。

结果

这项分析纳入了 52 名非洲裔患者和 85 名高加索患者。非洲裔患者更常见 III 类和孤立的 V 类 LN。两组之间首次肾脏缓解的时间无差异。相比之下,非洲裔患者更早出现肾脏发作,CKD 更为常见,且在发作后发生 CKD 的时间更短。在多变量分析中,非洲血统是进展为 CKD 的独立危险因素。我们未观察到两组之间在治疗不依从方面存在显著差异。

结论

非洲裔 LN 患者的肾脏预后较差,主要是由于肾脏发作率较高所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3f4/9608524/f7b54a30766d/rmdopen-2022-002386f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验